Funding for this research was provided by:
Vetenskapsrådet (2016-00906, 2018-02564)
Marianne and Marcus Wallenberg Foundation (2015.0125)
Multidisciplinary Research in Parkinson’s disease
Swedish Alzheimer Foundation (AF-939932)
The Parkinson foundation of Sweden (1280/20)
the Skåne University Hospital Foundation (2020-O000028)
Regionalt Forskningsstöd (2020-0314)
the Swedish federal government under the ALF agreement (2018-Projekt0279)
the National Institute of Neurological Disorders and Stroke (U24 NS072026)
National Institute on Aging (P30 AG19610)
Arizona Department of Health Services (211002)
Arizona Biomedical Research Commission (4001, 0011, 05-901, 1001)
Michael J. Fox Foundation for Parkinson's Research
Received: 22 December 2021
Accepted: 22 December 2021
First Online: 6 January 2022
: The procedures of brain tissue and plasma collection and forms were approved, for Cohort 1, by the medical ethics committee of VU medical center in Amsterdam (the Netherlands), for Cohort 2 by the Western Institutional Review Board of Puyallup, Washington (USA), and for this study by the regional ethical review board in Lund.
: Not applicable.
: OH has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from Roche, Genentech, Siemens, Biogen, Alzpath, and Cerveau.